RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3.

Yi NiuZiyou LinArabella WanHonglei ChenHeng LiangLei SunYuan WangXi LiXiao-Feng XiongBo WeiXiaobin WuGuohui Wan

Published in: Molecular cancer (2019)

Our findings demonstrate the functional significance of the m6A modification in breast cancer, and suggest that FTO may serve as a novel potential therapeutic target for breast cancer.

Keyphrases

poor prognosis
signaling pathway
risk assessment
long non coding rna
childhood cancer